The Institut Pasteur is a recognized public-interest private foundation that its founder, Louis Pasteur, wanted to be a scientific and medical research institute which also provides education and participates in improving public health. It now plays a key role in understanding, preventing and combating a large number of diseases, particularly infectious ones.
With this in mind, the Institut Pasteur has set up an international network of 32 branches across five continents which are all working towards the same goal: to prevent infectious diseases.
Another distinctive feature is the way its budget is constituted. Authorised to receive donations and legacies, the Institut Pasteur relies on three separate sources of funding: State grants, public generosity and profit from promoting its research.
A large number of infectious diseases, whether viral like AIDS, dengue fever or flu, bacterial like meningitis, fungal like aspergillosis, or parasitic like malaria, are under the microscope in our 130 research units. But we shouldn’t forget neuroscience, genomics, genetics or developmental biology which extend this already rich universe and are forming the basis for countless international partnerships.
Public health is also one of our priorities. The 21 National Reference Centers accredited by the French Institute for Public Health Surveillance and 7 WHO Collaborating Centers we host are proof of this. These laboratories are real watchdogs for infectious diseases. Moreover, the medical center specialising in travel medicine issues vaccinations, advice and health care particularly on infectious diseases.
The Institut Pasteur also welcomes young researchers every year to develop their knowledge. The Education Center gives its 525 students the opportunity to complete their studies through one of the 28 courses taught within a dynamic setting.
The Alliance is a unique springboard for developing synergies between its different partners and holding strategic discussions all together on the national research policy to be implemented. As a member of Aviesan’s Board of Directors, I would like the Institut Pasteur to play an active part, as it is the only private institution to belong. We are of course going to contribute our specialist knowledge and expertise in the field of emerging diseases, but also, and above all, in translational research, for which our teams are ensuring the medical application of research findings and vice versa.